Latest Profitability News

BPH Global Ltd reports a 17.7% revenue increase to A$177,316 in its second month of seaweed sales from Indonesia, signaling early commercial traction and sustainable growth potential.

Little Green Pharma reported a robust June 2025 quarter with record cash receipts and expanding European footprint, highlighted by a new production capacity in Denmark and the launch of its CherryCo brand in Germany.

Mirrabooka Investments reports a 26% drop in net profit for FY25 but maintains its fully franked dividend, supported by a significant $85 million capital raise. The fund’s portfolio return lags the benchmark amid sector headwinds, yet long-term performance remains robust.

Vinyl Group Ltd reports a 17% quarterly increase in cash receipts to $3.786 million, driven by acquisitions and platform growth, while targeting cash-flow breakeven by Q2 FY26 through operational efficiencies and margin improvements.

Prospect Resources has released compelling metallurgical test results from its Mumbezhi Copper Project in Zambia, demonstrating robust, high-grade copper concentrates and strong recoveries that support plans for a central processing hub.

CAR Group announces a leadership transition with CFO William Elliott set to succeed long-serving CEO Cameron McIntyre, alongside an upbeat FY25 financial outlook signaling robust revenue and profit growth.

Complii FinTech Solutions reported an 11.8% increase in customer receipts for Q4 FY25, alongside a 4.3% quarterly rise in annual recurring revenue, underscoring its expanding footprint in capital raising and compliance software.

betr Entertainment has unveiled an all-scrip takeover bid for PointsBet, offering shareholders 3.81 betr shares per PointsBet share, valuing the offer above a competing cash bid and promising significant cost synergies.

Lumos Diagnostics Holdings Limited has had its ASX trading suspension lifted following news of a strategic material agreement, signaling potential growth ahead.

Future Generation Global has reported a strong 20.8% investment portfolio return for the year ending June 2025, prompting an increase in its fully franked interim dividend to 4.0 cents per share. This marks the sixth consecutive year of dividend growth for the ASX-listed investment company.

ImpediMed has doubled its US unit sales in Q4 FY25, achieving a record total contract value and securing an additional $5 million tranche under its growth capital facility.

Close the Loop Limited announces a strategic leadership overhaul with new CEOs appointed for North America and Australia, alongside a streamlined operational focus on three core business units.